Subscribe To
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Eur/usd: bulls hold grip but caution on growing signals of pullback
The Euro has established above psychological 1.10 level and holding gains above former top at 1.1032, with Friday’s upside extension to new one-year...
April 14, 2023, 11:27 am
Ion energy progresses toward ni 43-101 resource estimate with hydrogeological studies at mongolia lithium project
ION Energy Limited announced that hydrogeological studies have commenced at its Urgakh Naran lithium pr...
April 12, 2023, 12:26 pm
Merck shares fall after us fda halts new patient enrollment of ms drug candidate trials
The US Food and Drug Administration has hit pause on patient enrollment for German drugmaker Merck's multiple sclerosis drug candidate evobrutinib aft...
April 12, 2023, 9:38 am
First mining gold says 2022 drilling program expands mineralization potential at springpole with sw extension zone
First Mining Gold Corp. (TSX:FF, OTCQX:FFMGF) told investors it has identified additional mineralization in the SW Extension Zone during its 2022 dri...
April 12, 2023, 8:31 am
Abbvie (abbv), j&j to withdraw 2 blood cancer nods for imbruvica
AbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two blood cancer treatments is based on confirmatory ...
April 10, 2023, 12:09 pm
Reasons to retain shockwave medical (swav) in your portfolio
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies<...
April 10, 2023, 9:54 am
Merck (mrk) keytruda studies in difficult-to-treat cancers fail
Merck (MRK) and Eisai announce the discontinuation of the phase III LEAP-003 study seeking approval of the Keytruda and Lenvima combo. Another phase I...
April 10, 2023, 9:54 am
Voyageur pharmaceuticals reports positive comparative study of smoothx barium contrast media for ct imaging
Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) said it has completed comparative studies of its Sm...
April 4, 2023, 9:19 am
Mersana therapeutics: unrecognized promise in upri's cancer fight
Concerns related to safety risks around ILD/pneumonitis are overblown in a disease of high unmet needs. I believe clinical benefits outweigh potential...
April 3, 2023, 5:20 pm
Kodiak sciences (kod) shares are up 26% in a week: here's why
Shares of Kodiak Sciences (KOD) shot up 26% in the last week after the company announced remaining on track with ongoing ...
April 3, 2023, 12:55 pm
Good reasons to avoid esg offenders
One of the benefits of the environmental, social, and governance (ESG) investing movement is that it spurred a raft of research and ...
March 31, 2023, 10:22 am
Innovative program to support children in prayer and worship receives lilly endowment inc. grant
Funds will support the creation of programs of liturgical catechesis to benefit children in dioceses and parishes around the nation. Washington, D.C.,...
March 30, 2023, 2:29 pm
Perimeter medical imaging ai highlights new publication featuring commercial use of perimeter s-series oct
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) announced the publication of a new white paper featuring three case ...
March 29, 2023, 9:41 am
Betterlife pharma says betr-001 drug candidate featured in drug discovery & development article
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an article titled “Non-hallucinogenic LSD derivative reduces depression symptoms in...
March 29, 2023, 9:31 am
Allarity's stock falls after saying enrollment in two clinical trials is slow
Shares of Allarity Therapeutics Inc. ALLR, -4.51% plunged 17% in premarket trading on Tuesday after the company told investors that it's struggled to ...
March 28, 2023, 8:34 am
Ambrx to present preclinical data on arx517 and arx305 at the 2023 aacr annual meeting
Three posters will be presented at AACR and include data from preclinical studies of ARX517 and ARX305 ...
March 27, 2023, 8:30 am
Abbvie (abbv) provides clinical updates on inflammatory drugs
AbbVie???s (ABBV) two studies evaluating Skyrizi in ulcerative colitis and Rinvoq in systemic lupus ery...
March 24, 2023, 2:28 pm
Gsk says it disagrees with california state court ruling on zantac
U.K. pharmaceutical giant GSK on Friday said it disagreed with a California state court ruling on Zantac, or ranitidine, and its links with cancer. �...
March 24, 2023, 6:13 am
Imunon to hold fourth quarter 2022 financial results and business update conference call on thursday, march 30, 2023
LAWRENCEVILLE, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing ...
March 23, 2023, 8:30 am